Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

NCT03124212 is registered in ClinicalTrials.gov with University of Basel as lead sponsor.

NCT NCT03124212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03124212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
Lead sponsor
University of Basel
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2017
Completion date
January 31, 2035
Enrollment
700 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary breast and ovarian cancer, lynch syndrome